Topic: Pfizer Inc.

Panel cites benefits of Pfizer osteoporosis drug

AP Features - 725 days ago
An experimental drug from Pfizer could benefit certain women with osteoporosis, federal advisers said Monday, despite concerns of side effects. A Food and Drug Administration panel of experts voted 9-3 that the benefits of Fablyn could outweigh its risks, including blood clots ...
Read More...

FDA wary of deaths with Pfizer osteoporosis drug

AP Features - 731 days ago
Federal regulators say a drug from Pfizer and Ligand Pharmaceuticals effectively treats osteoporosis, though they are concerned about deaths, blood clots and other problems seen in company studies. The Food and Drug Administration noted Thursday that women treated with Pfizer's Fablyn were ...
Read More...